Meret Gaugler

Meret is a Partner at Endeavour Vision, helping shape both the near- and long-term direction of the firm’s investments. Meret was on Endeavour Vision’s deal team for investments in Virtual Incision Corporation, SOPHiA GENETICS (NASDAQ:SOPH) and CeQur. She represents Endeavour Vision on the board of CeQur.

Prior to joining the Endeavour Vision team, Meret successfully managed a range of Swiss and international equity portfolios at Lombard Odier Investment Managers. Over the course of nearly 10 years, she earned a reputation as a leading healthcare specialist and opinion shaper in Switzerland.

Meret brings a unique blend of scientific acumen and a deep, differentiated overview of the healthcare sector. She holds a Master’s degree in natural sciences from the ETH Zurich and a PhD in neuroscience from the EPFL Lausanne.